BTTC

Black Titan Corporation Ordinary Shares (BTTC)

Stock · NASDAQ · Health Care

$0.4334as of 8/28/2026

Active signals

High Beta88.3%
Resistance level
$0.757719
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

How Black Titan Corporation Ordinary Shares Makes Money

Where the revenue actually goes — FY2023 annual results

market-wall.comTotalRevenue$308SG&A$819.0K (265909%)BTTC

Source: 10-K filed Apr 1, 2024 · via SEC EDGAR / Finnhub

Black Titan Corporation Ordinary Shares Competitors

Chosen by industry and closest market cap.

  • BTTC
    Black Titan Corporation Ordinary Shares
    $0.4334
    ▼ 7.98%
    Market cap $1.02MP/E
  • SCNI
    Scinai Immunotherapeutics Ltd. American Depositary Shares
    $2.53
    ▼ 5.60%
    Market cap $1.30MP/E 0.14
    $2.15$16.8
  • PHGE
    BiomX Inc. COmmon Stock
    $0.138
    ▲ 4.55%
    Market cap $3.95MP/E
    $0.1192$12.29
  • VIVS
    VivoSim Labs Inc. Common Stock
    $0.29
    ▲ 0.00%
    Market cap $5.53MP/E
    $0.2625$5.3
  • AIM
    AIM ImmunoTech Inc. Common Stock
    $0.2558
    ▲ 2.32%
    Market cap $7.51MP/E
    $0.1901$2.89
  • CRIS
    Curis Inc. Common Stock
    $1.49
    ▲ 2.76%
    Market cap $8.59MP/E
    $1.4$39
  • BCDA
    BioCardia Inc. Common Stock
    $1.16
    ▼ 0.85%
    Market cap $10.80MP/E
    $0.75$2.29

P/E shows — for peers not currently carrying a live signal of their own.

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.